Women's Use of Alternative Medicine: A Multiethnic Study
February 26, 2007 updated by: National Center for Complementary and Integrative Health (NCCIH)
The purpose of this study is to examine socio-cultural factors of women's use of complementary and alternative medicine (CAM).
The effects of socioeconomic status, social networks and acculturation on CAM use will be assessed among white, African-, Mexican-, and Chinese-American women.
Study Overview
Status
Completed
Study Type
Observational
Enrollment
3200
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion criteria:
Experienced one or more of the following health conditions within the last year:
- pregnancy related symptoms
- menopausal related symptoms
- headaches
- back pain
- osteoporosis
- cancer
- high blood pressure
- high cholesterol
- heart disease
- joint pain/arthritis
- insomnia
- uterine fibroids
- urinary tract infection
- vaginal tract infection
- medically diagnosed depression
- menstrual symptoms
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Natural History
- Time Perspectives: Other
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Fredi Kronenberg, PhD, Rosenthal Center for Complementary and Alternative Medicine, Columbia University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2001
Study Completion
September 1, 2001
Study Registration Dates
First Submitted
August 13, 2003
First Submitted That Met QC Criteria
August 14, 2003
First Posted (Estimate)
August 15, 2003
Study Record Updates
Last Update Posted (Estimate)
February 27, 2007
Last Update Submitted That Met QC Criteria
February 26, 2007
Last Verified
February 1, 2007
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Cardiovascular Diseases
- Vascular Diseases
- Metabolic Diseases
- Infections
- Neoplasms, Connective and Soft Tissue
- Neoplasms by Histologic Type
- Neoplasms
- Urologic Diseases
- Pain
- Neurologic Manifestations
- Musculoskeletal Diseases
- Bone Diseases
- Bone Diseases, Metabolic
- Neoplasms, Muscle Tissue
- Heart Diseases
- Hypertension
- Urinary Tract Infections
- Headache
- Osteoporosis
- Leiomyoma
Other Study ID Numbers
- F31AT001401-01 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.